Xyosted 100 MG/0.5 ML auto-INJ 0.5ML

Ended Awarded

Contract number
SPE2DB23FS5YL
Awardee
Awarding agency
Obligated
$359

Award facts

Contract value 100% obligated
$359.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $359,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania through August 2021. The award was made utilizing the Prime Vendor Program indefinite-delivery/indefinite-quantity contract vehicle. No set-aside provisions or subcontractors were identified. This supports the DLA's mission to provide medical supplies and pharmaceuticals to military treatment facilities worldwide.

Quick answers

Who was awarded contract SPE2DB23FS5YL?

SPE2DB23FS5YL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2023.

How much is contract SPE2DB23FS5YL worth?

The government has obligated $359 on SPE2DB23FS5YL.

Is contract SPE2DB23FS5YL an order under another contract?

Yes. SPE2DB23FS5YL is a delivery order under SPE2DB22D2214, an indefinite delivery contract.

Was contract SPE2DB23FS5YL competed?

The extent of competition for SPE2DB23FS5YL was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award